Literature DB >> 32841823

Efficacy of an Enhanced Recovery After Surgery (ERAS) Pathway in Elderly Patients Undergoing Spine and Peripheral Nerve Surgery.

Joseph Ifrach1, Rohan Basu1, Disha S Joshi1, Tracy M Flanders2, Ali K Ozturk1, Neil R Malhotra1, Rachel Pessoa1, Michael J Kallan3, Eileen Maloney1, William C Welch1, Zarina S Ali4.   

Abstract

OBJECTIVE: Elderly patients are a vulnerable patient population in elective spinal surgery. Older patients have more medical comorbidities and are also more sensitive to opiate medications. Despite this, spine and peripheral nerve surgery is still feasible in these patients, and an Enhanced Recovery After Surgery (ERAS) regimen can further enhance the safety profile.
METHODS: This is a before and after cohort study at a single institution on elderly patients who underwent elective spine and peripheral nerve surgery. Patients were prospectively enrolled in a novel ERAS protocol from April 2017 to December 2018. The control group was a historical cohort of patients who underwent surgery from September 2016 to December 2016. The primary outcome was self-reported opioid use at 1- and 3-months postoperatively. The secondary outcome was compliance with the ERAS protocol across several measures including patient-controlled (PCA) use, patient-reported pain scores, mobilization and ambulation status, and Foley catheter use.
RESULTS: Among 504 patients aged 65 and older compared to historic controls there was a significant reduction in the use of post-operative opioids at one month (36.2% vs. 71.7%, p < 0.001) and 3 months after surgery (33.0% vs. 80.0%, p < 0.001). 504 consecutive elderly patients were included in the ERAS protocol compared to a control group of 60. The two groups had similar surgical procedures and baseline demographics, with similar mean ages (ERAS 73.2 years vs. control 73.5 years, p = 0.67). The ERAS group showed improved mobilization and ambulation on POD 0 in compliance with our protocol compared to the control group (mobilization: 60.0% vs. 10.0%, p < 0.001; ambulation: 36.1% vs. 10.0%, p < 0.001), with no inpatient falls reported for either group.
CONCLUSIONS: ERAS facilitates reduction in opiate use at 1- and 3-month intervals postoperatively in patients greater than 65 years old undergoing elective spine and peripheral nerve surgery. Early mobilization and ambulation are safe and feasible in this population.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  elderly; enhanced recovery after surgery (ERAS); opioid; spine surgery

Mesh:

Substances:

Year:  2020        PMID: 32841823     DOI: 10.1016/j.clineuro.2020.106115

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  5 in total

1.  Enhanced recovery after surgery (ERAS) protocol in spine surgery.

Authors:  Tungish Bansal; Alok D Sharan; Bhavuk Garg
Journal:  J Clin Orthop Trauma       Date:  2022-07-09

2.  Model-Based Computational Analysis on the Effectiveness of Enhanced Recovery after Surgery in the Operating Room with Nursing.

Authors:  Wenji Li; Shu Huang; Yong Xie; Guanyu Chen; Jun Yuan; Yun Yang
Journal:  Front Surg       Date:  2022-05-18

3.  Enhanced Recovery After Surgery Protocol in Minimally Invasive Lumbar Fusion Surgery Reduces Length of Hospital Stay and Inpatient Narcotic Use.

Authors:  Isabelle C Band; Altan O Yenicay; Tina D Montemurno; Jenny S Chan; Alfred T Ogden
Journal:  World Neurosurg X       Date:  2022-02-04

4.  Continued Increase in Cost of Care Despite Decrease in Stay After Posterior Spinal Fusion for Adolescent Idiopathic Scoliosis.

Authors:  K Aaron Shaw; Brittany Ange; Varghese George; Joshua S Murphy; Nicholas D Fletcher
Journal:  J Am Acad Orthop Surg Glob Res Rev       Date:  2022-03-11

5.  Can the Full-Percutaneous Endoscopic Lumbar Discectomy in Day Surgery Mode Achieve Better Outcomes Following Enhanced Recovery after Surgery Protocol? A Retrospective Comparative Study.

Authors:  Le Kou; Wentao Wan; Chao Chen; Dong Zhao; Xun Sun; Ziwei Gao; Hongjin Wu; Mingyuan Di; Xinlong Ma; Baoshan Xu; Jun Miao; Zheng Wang; Qiang Yang
Journal:  Front Surg       Date:  2022-05-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.